or Try an Advanced Search...

    Technical Analysis for DNTH - Dianthus Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 20.35 -2.02% -0.42
    DNTH closed down 6.74 percent on Wednesday, November 20, 2024, on 72 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DNTH trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness -2.02%
    Wide Bands Range Expansion -2.02%
    Below Lower BB Weakness -2.02%
    Lower Bollinger Band Touch Weakness -2.02%
    Oversold Stochastic Weakness -2.02%
    Stochastic Buy Signal Bullish -8.62%
    Lower Bollinger Band Walk Weakness -8.62%
    Below Lower BB Weakness -8.62%
    Gapped Down Weakness -8.62%
    Lower Bollinger Band Touch Weakness -8.62%
    Older End-of-Day Signals for DNTH ...

       Recent Intraday Alerts

    Alert Time
    Down 3% 21 minutes ago
    Down 2 % 21 minutes ago
    Rose Above Lower Bollinger Band 27 minutes ago
    Fell Below Previous Day's Low 27 minutes ago
    Down 1% 27 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DNTH Chart by TradingView
    Basic chart:

    Profile

    Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs and delivers novel monoclonal antibodies. It develops monoclonal antibodies and complement therapeutics to deliver transformative medicines for patients with rare diseases. Dianthus Therapeutics, Inc. was incorporated in 2019 and is based in Waltham, Massachusetts, with an additional office in New York, New York
    Classification
    Keywords: Biotechnology Immunology Immune System Antibodies Rare Diseases Monoclonal Antibody Antibody

    Is DNTH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Nov 10 Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 8 Dianthus Therapeutics GAAP EPS of -$0.74, revenue of $2.17M
    Nov 7 Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
    Nov 4 Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
    Oct 15 Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting
    Oct 8 Dianthus: Modest Opportunity With 2 Caveats
    Oct 3 Dianthus started at outperform by Oppenheimer on DNTH103 opportunity
    Oct 1 Dianthus Therapeutics files $500M mixed shelf offering
    Sep 4 Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
    See more DNTH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.77
    52 Week Low 6.58
    Average Volume 269,373
    200-Day Moving Average 26.20
    50-Day Moving Average 27.25
    20-Day Moving Average 26.90
    10-Day Moving Average 25.62
    Average True Range 1.85
    RSI (14) 23.66
    ADX 16.12
    +DI 14.01
    -DI 30.44
    Chandelier Exit (Long, 3 ATRs) 26.71
    Chandelier Exit (Short, 3 ATRs) 26.09
    Upper Bollinger Bands 31.77
    Lower Bollinger Band 22.03
    Percent B (%b) -0.13
    BandWidth 36.21
    MACD Line -1.34
    MACD Signal Line -0.52
    MACD Histogram -0.8162
    Fundamentals Value
    Market Cap 608.94 Million
    Num Shares 29.3 Million
    EPS -2.91
    Price-to-Earnings (P/E) Ratio -7.14
    Price-to-Sales 147.91
    Price-to-Book 2.94
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.65
    Resistance 3 (R3) 23.89 23.17 23.17
    Resistance 2 (R2) 23.17 22.44 23.05 23.01
    Resistance 1 (R1) 21.97 21.98 21.61 21.73 22.85
    Pivot Point 21.25 21.25 21.07 21.13 21.25
    Support 1 (S1) 20.05 20.52 19.69 19.81 18.69
    Support 2 (S2) 19.33 20.06 19.21 18.53
    Support 3 (S3) 18.13 19.33 18.37
    Support 4 (S4) 17.89